Furthermore, our in vitro study demonstrated that knock-down of CAT-1 in CRC cells induced apoptosis and inhibited cell growth, suggesting that CAT-1 may be a unique molecular biomarker and therapeutic target of CRC. Here, SLC7A1 is linked to colorectal carcinoma.